Search results
Results from the WOW.Com Content Network
The British National Formulary (BNF) is a United Kingdom (UK) pharmaceutical reference book that contains a wide spectrum of information and advice on prescribing and pharmacology, along with specific facts and details about many medicines available on the UK National Health Service (NHS).
The BNF for Children developed from the British National Formulary (BNF), which prior to 2005 had provided information on the treatment of children, with the doses largely determined by calculations based on the body weight of the child. The guidance was provided by pharmacists and doctors whose expertise was in the care of adults.
The two main reference sources providing this information are the British National Formulary (BNF) and the Drug Tariff. There is a section in the Drug Tariff, known unofficially as the " Blacklist ", detailing medicines which are not to be prescribed under the NHS and must be paid for privately by the patient.
The British Pharmacopoeia is an important statutory component in the control of medicines, which complements and assists the licensing and inspection processes of the UK's Medicines and Healthcare products Regulatory Agency (MHRA). Together with the British National Formulary (BNF), the British Pharmacopoeia defines the UK's pharmaceutical ...
The Pharmaceutical Society of Great Britain was founded on 15 April 1841 [1] by William Allen FRS, Jacob Bell, Daniel Hanbury, John Bell, Andrew Ure, James Marwood Hucklebridge, and other London chemists and druggists, at a meeting in the Crown and Anchor Tavern, Strand, London.
British National Formulary and British National Formulary for Children – the UK standard reference in the use and selection of medicines, published in conjunction with the BMJ Group.
Main page; Contents; Current events; Random article; About Wikipedia; Contact us; Help; Learn to edit; Community portal; Recent changes; Upload file
In March 1995 the £9 billion acquisition of Wellcome by Glaxo was completed, forming Glaxo Wellcome, in what was the largest merger in UK corporate history to date. [20] BASF completed the acquisition of the pharmaceutical division of The Boots Company in April 1995. [ 21 ]